Esomeprazole Magnesium Capsule, Delayed Release Pellets
Product Images NDC 0378-2351

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Esomeprazole Magnesium (NDC 0378-2351). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Esomeprazole Magnesium Structural Formula (Image 01)

Chemical structure of Esomeprazole Magnesium, showing the molecular arrangement including the magnesium ion (Mg2+) components associated with the compound.*

FDA Label Image

Figure 2: Maintenance Of Healing Rates By Month (study 177) (Image 02)

A line graph showing the percentage of patients maintaining a condition over a six-month period with scheduled visits. The graph compares four groups: Esomeprazole Magnesium 40 mg, 20 mg, 10 mg, and placebo, indicating dose-dependent differences in maintenance rates across months.*

FDA Label Image

Figure 3: Maintenance Of Healing Rates By Month (study 178) (Image 03)

A line graph showing the percent maintained over 6 months during scheduled visits for groups receiving Esomeprazole 40 mg, 20 mg, 10 mg, and placebo. The graph includes data points representing the percentage maintained for each treatment group across the time period.*

FDA Label Image

Figure 4: Percent Of Patients Symptom-free Of Heartburn By Day (study 225) (Image 04)

A line graph showing the percent of patients symptom-free over 28 diary days for Esomeprazole Magnesium 40 mg, 20 mg, and placebo groups. The Y-axis indicates percent symptom-free patients from 0 to 100%, and the X-axis represents diary days from 0 to 28. The graph compares symptom relief trends between the two dosages and placebo over time.*

FDA Label Image

Figure 5: Percent Of Patients Symptom-free Of Heartburn By Day (study 226) (Image 05)

A line graph showing the percent of patients symptom-free over 28 diary days for Esomeprazole 40 mg, Esomeprazole 20 mg, and placebo. The graph indicates higher symptom-free percentages for both Esomeprazole doses compared to placebo throughout the period.*

FDA Label Image

Esomeprazole Magnesium Delayed-release Capsules, Usp 20 mg Bottle Label (Image 06)

Label for Esomeprazole Magnesium delayed-release capsules, USP, 20 mg strength, manufacturer's Mylan Pharmaceuticals Inc. The label indicates a 30-capsule bottle, with dosage form as delayed-release pellets in capsules for oral use. Storage instructions and warnings about child safety and medication guidance are included. The label displays NDC 0378-2350-93 and barcodes for scanning.*

FDA Label Image

Esomeprazole Magnesium Delayed-release Capsules, Usp 40 mg Bottle Label (Image 07)

Label for Esomeprazole Magnesium Delayed-Release Capsules, USP 40 mg by Mylan Pharmaceuticals Inc., containing 30 capsules. The label includes the NDC 0378-2351-93, storage instructions, manufacturer location (Morgantown, WV), and child-resistant container information. It specifies that each delayed-release capsule contains 44.50 mg of esomeprazole magnesium, USP equivalent to 40 mg of esomeprazole.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.